Product
Ritonavir + Pyramax
1 clinical trial
1 indication
Indication
MalariaClinical trial
Open-label, Randomised, Drug Interaction Study of Pyramax (Pyronaridine Artesunate) and the Protease Inhibitor Ritonavir in Healthy VolunteersStatus: Completed, Estimated PCD: 2010-08-01